Uncovering the Hidden Connection: GLP-1 and Emotional Regulation of Eating
The notion that medications for weight management primarily affect appetite and satiety has led to a fascinating area of exploration – the relationship between GLP-1 and emotional regulation of eating. This narrative review synthesizes emerging evidence on how GLP-1 receptor agonists (GLP-1RAs) shape eating behaviors, emotions, and body image, raising new challenges for eating disorder research and clinical care.
The Science Behind GLP-1 and Emotional Regulation
GLP-1, a naturally occurring hormone in the gut, plays a crucial role in regulating blood sugar levels and appetite signals. Its release after eating communicates with the brain, influencing hunger and satiety hormones. When we consume food, GLP-1 is secreted, signaling the brain to release insulin, tell the liver to slow glucose production, and reduce hunger and food cravings.
As a result, GLP-1RAs, such as semaglutide and liraglutide, have revolutionized weight management by slowing gastric emptying, increasing satiety, reducing hunger and food cravings, and influencing reward pathways related to eating behavior. But how do these compounds interact with emotions and psychological functioning?
From Weight Loss to Emotional Balance
Studies have revealed that GLP-1RAs can have broader effects, including improved mood, reduced anxiety around food, and a decrease in depressive symptoms. The overlap of GLP-1 pathways with those involved in emotional and psychological functioning may result in effects extending beyond weight management. By changing the underlying biology of eating, GLP-1RAs may be beneficial for individuals struggling with emotional eating.
